Replimune plans layoffs as FDA rejects cancer drug

Replimune (REPL) stock plunges as the company seeks layoffs following the FDA rejection of its cancer drug RP1 for melanoma.
MarketWatch

U.S. Economic Calendar

The median forecasts in this calendar come from surveys of economists conducted by Dow Jones Newswires and The Wall Street Journal. All statistics in this calendar are in expressed in nominal terms ...
The Daily Courier

Talking Money: Why does the price of gas increase fast and come down slow?

Here we go again. So many times (over my 28-year-and-counting career) have we experienced a temporary (and not-so-temporary) ...
The Times of Northwest Indiana

CASA's Pinwheel Day marks Child Abuse Prevention Month

Staff and volunteers in the Lake County Court Appointed Special Advocate, or CASA, program, observed Child Abuse Prevention Month on Friday with their annual Pinwheel Day, during which participants pl ...